Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

• Status: Completed
• Trial end date: 2014-06-30
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to prove that luteal phase supplementation with recombinant LH can solve the luteal phase deficiency after Gnrh agonist oocytes triggering in women at risk of OHSS

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: San Carlo Public Hospital, Potenza, Italy
• Treatments: Deslorelin

Criteria

Inclusion Criteria:

• patients with an oestradiol > 4000 pg/ml on the oocytes triggering day

• patient with more than 24 follicles of diameter greater than 12 mm on the oocytes triggering day

Exclusion Criteria:

• patients with no risk of OHSS on the oocytes triggering day

• patients with an oestradiol < 4000 pg/ml on the oocytes triggering day

• patient with less than 24 follicles of diameter greater than 12 mm on the oocytes triggering day